+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunochemicals Market by Product Type, Application, End User, Technology, Format, Label Type - Global Forecast to 2030- Product Image
Immunochemicals Market by Product Type, Application, End User, Technology, Format, Label Type - Global Forecast to 2030- Product Image
Sale

Immunochemicals Market by Product Type, Application, End User, Technology, Format, Label Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889477
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Immunochemicals Market is poised for significant growth, evolving from USD 3.12 billion in 2024 to USD 3.35 billion in 2025 and projected to reach USD 4.76 billion by 2030, driven by a CAGR of 7.27%.

Foundation of the Immunochemicals Market

The immunochemicals sector is undergoing rapid transformation due to biotechnology advancements, rising precision diagnostics demand, and pioneering assay techniques. As laboratories shift to efficient workflows and specialized analytical solutions, immunochemicals play a crucial role in both research and clinical settings. This executive summary outlines essential dynamics in the market, enabling stakeholders to effectively manage supply chain transitions, adapt to regulatory changes, and meet emerging user demands. Understanding these growth drivers empowers decision-makers to leverage high-potential segments and anticipate sector challenges.

Transformational Industry Dynamics

Recent years have seen transformative shifts in immunochemicals, challenging traditional industry paradigms. Single-cell analysis and high-throughput screening technologies expand understanding of cellular diversity and disease mechanisms. Digital platforms also enhance assay development and data analytics, speeding up insights. The personalization movement requires specific antibody reagents and peptide antigens, prompting suppliers to innovate with scalable recombinant technologies. Concurrently, supply chain disruptions and regulatory shifts drive improved sourcing strategies and strategic manufacturing partnerships. These changes collectively advance technological innovation, supply chain optimization, and customer-driven service models in immunochemicals.

Impact of United States Tariffs in 2025

The 2025 U.S. tariffs significantly impact immunochemicals, increasing costs for raw materials like proteins and polymer reagents. This pressure compels companies to reevaluate pricing and operational strategies. Some firms now invest in tariff-free sources or domestic production to mitigate risks. These tariffs influence capital allocations, encouraging automation to manage expenses and inspire consolidation for scale economies and supplier leverage. Adaptation to this trade landscape requires resilience and agility to secure competitive positions post-tariff.

Key Takeaways from This Report

  • Immunochemicals market growth is driven by biotechnology advances, personalized medicine demands, and novel assay techniques.
  • U.S. tariffs present challenges but also opportunities for strategic resource allocation and supply chain adjustments, leading to potential competitive advantages.
  • Technological innovations and ecosystem shifts allow for innovative service models that meet the demands of precision medicine and efficient laboratory workflows.
  • Stakeholders can leverage detailed market segments for strategic planning and identifying high-growth opportunities in the immunochemicals sector.

Regional Market Varieties

Regional dynamics play a significant role in shaping market growth. In the Americas, strong translational research and biotechnology ecosystems stimulate advanced antibody formats and multiplex assays. North American labs favor high-sensitivity reagents, enhancing demand for premium products. In Europe, Middle East, and Africa, stringent quality and sustainability priorities impact product adoption. Emerging markets here are rapidly expanding labs and research organizations. The Asia-Pacific region leads in pharmaceutical and biotech expansion, supported by government research funding and growing clinical trial activity, increasing demand for reagents and kits.

Leading Innovators in the Industry

The competitive landscape in immunochemicals is characterized by relentless innovation and strategic collaborations. Major companies focus on next-generation antibodies and expanding portfolios through acquisitions. Partnerships between reagent and instrument producers offer users seamless workflows and improved data quality. Midsize firms tap into niche markets with expertise in custom reagent development, often partnering with academic entities for unmet clinical needs. Global distributors enhance digital catalogs and delivery efficiency to meet modern supply chain demands. Overall, sustainable practices and regulatory compliance remain core to building customer trust and market leadership.

Actionable Strategies for Market Leaders

Industry leaders should adopt a multi-pronged strategy aligning innovation, operational efficiency, and customer engagement. Modular production facilitates rapid scaling and customization. Regional collaborations expand market access in emerging areas. Digital transformation enhances inventory management and forecasts demand more accurately. Proactive regulatory engagement eases approvals and bolsters brand credibility. Leaders focusing on sustainability and transparency can differentiate and mitigate risks amid evolving customer preferences.

Comprehensive Research Methodology

Our holistic research approach encompasses primary and secondary methodologies. Interviews with industry experts provided firsthand insights into technology adoption and challenges. Comprehensive reviews of academic journals and corporate data validated industry trends. Triangulated data ensured robust analyses, supported by detailed case studies. Final validation workshops with experts confirmed the accuracy and feasibility of strategic recommendations.

Synthesizing a Path Forward

The immunochemicals market is at a critical juncture where technological, regulatory, and economic influences are converging. This report highlights rich opportunities for agile stakeholders navigating supply chains, tariff environments, and user requirements. Embracing antibody innovation, data-driven models, and strategic partnerships pave the way for growth. Acknowledging 2025 tariff impacts reinforces the need for agility and strategic foresight. As the industry adapts, continued R&D and regulatory focus will ensure sustained success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immunochemicals Market, by Product Type
8.1. Introduction
8.2. Antibodies
8.2.1. Monoclonal
8.2.1.1. Humanized
8.2.1.2. Mouse
8.2.1.3. Rabbit
8.2.2. Polyclonal
8.2.2.1. Goat
8.2.2.2. Rabbit
8.2.3. Recombinant
8.2.3.1. Fusion
8.2.3.2. Single Chain
8.3. Antigens
8.3.1. Haptens
8.3.2. Peptide Antigens
8.3.2.1. Catalog Peptide
8.3.2.2. Custom Peptide
8.3.3. Protein Antigens
8.3.3.1. Purified Protein
8.3.3.2. Recombinant Protein
8.4. Kits
8.4.1. Elisa Kits
8.4.1.1. Competitive Elisa
8.4.1.2. Indirect Elisa
8.4.1.3. Sandwich Elisa
8.4.2. Flow Cytometry Kits
8.4.3. Ihc Kits
8.4.3.1. Direct Immunoperoxidase
8.4.3.2. Indirect Immunoperoxidase
8.4.4. Western Blot Kits
8.4.4.1. Semi Dry Transfer
8.4.4.2. Wet Transfer
8.5. Reagents
8.5.1. Blocking Agents
8.5.2. Buffers and Destainers
8.5.3. Secondary Antibodies
8.5.3.1. Conjugated
8.5.3.2. Unconjugated
8.5.4. Substrates
9. Immunochemicals Market, by Application
9.1. Introduction
9.2. Clinical Research
9.3. Diagnostics
9.4. Drug Discovery
9.5. Research
10. Immunochemicals Market, by End User
10.1. Introduction
10.2. Academic Institutes
10.3. Contract Research Organizations
10.4. Diagnostic Laboratories
10.5. Pharmaceutical Biotech Companies
11. Immunochemicals Market, by Technology
11.1. Introduction
11.2. Elisa
11.3. Flow Cytometry
11.3.1. Cell Surface Analysis
11.3.2. Intracellular Analysis
11.4. Immunohistochemistry
11.5. Western Blot
12. Immunochemicals Market, by Format
12.1. Introduction
12.2. Liquid
12.3. Lyophilized
13. Immunochemicals Market, by Label Type
13.1. Introduction
13.2. Enzyme
13.3. Fluorescent
13.4. Luminescent
13.5. Radioactive
14. Americas Immunochemicals Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Immunochemicals Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Immunochemicals Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Danaher Corporation
17.3.3. Merck KGaA
17.3.4. Agilent Technologies, Inc.
17.3.5. Bio-Rad Laboratories, Inc.
17.3.6. PerkinElmer, Inc.
17.3.7. Becton, Dickinson and Company
17.3.8. Abcam plc
17.3.9. Bio-Techne Corporation
17.3.10. Promega Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. IMMUNOCHEMICALS MARKET MULTI-CURRENCY
FIGURE 2. IMMUNOCHEMICALS MARKET MULTI-LANGUAGE
FIGURE 3. IMMUNOCHEMICALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL IMMUNOCHEMICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. IMMUNOCHEMICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. IMMUNOCHEMICALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. IMMUNOCHEMICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNOCHEMICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY HUMANIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY MOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RABBIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY GOAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RABBIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SINGLE CHAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY HAPTENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CATALOG PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CUSTOM PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PURIFIED PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DIRECT IMMUNOPEROXIDASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY INDIRECT IMMUNOPEROXIDASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SEMI DRY TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WET TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY BLOCKING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY BUFFERS AND DESTAINERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CONJUGATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY UNCONJUGATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CELL SURFACE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY INTRACELLULAR ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ENZYME, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLUORESCENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LUMINESCENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RADIOACTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 126. CANADA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. CANADA IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 128. CANADA IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 129. CANADA IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 130. CANADA IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 131. CANADA IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 132. CANADA IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 133. CANADA IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 134. CANADA IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 135. CANADA IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 136. CANADA IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 137. CANADA IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 138. CANADA IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 139. CANADA IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 140. CANADA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. CANADA IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. CANADA IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. CANADA IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 144. CANADA IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 145. CANADA IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 146. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 148. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 149. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 150. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 151. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 152. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 153. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 155. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 158. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 164. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 165. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 195. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 196. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 197. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 198. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 199. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 200. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 204. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 205. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 246. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 247. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 249. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 250. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 251. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 252. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 253. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 254. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 255. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 256. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 257. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 258. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 259. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 260. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 261. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 265. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 266. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 267. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 269. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 270. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 271. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 272. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 273. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 274. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 275. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 276. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 277. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 278. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 279. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 280. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 281. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 285. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 286. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 287. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 289. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 290. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 291. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 292. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 307. ITALY IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. ITALY IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 309. ITALY IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 310. ITALY IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 311. ITALY IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 312. ITALY IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 313. ITALY IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 314. ITALY IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 315. ITALY IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 316. ITALY IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 317. ITALY IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 318. ITALY IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 319. ITALY IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 320. ITALY IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 321. ITALY IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. ITALY IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. ITALY IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. ITALY IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 325. ITALY IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 326. ITALY IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 327. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 329. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 330. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 331. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 332. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 333. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 334. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 335. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 336. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 337. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 338. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 339. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 340. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 341. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 342. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 344. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 345. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 346. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2030 (USD MILLION)
TABLE 347. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 348. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2030 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2030 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES IMMUNO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Immunochemicals market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Becton, Dickinson and Company
  • Abcam plc
  • Bio-Techne Corporation
  • Promega Corporation

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.76 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Immunochemicals - Global Strategic Business Report - Product Image

Immunochemicals - Global Strategic Business Report

  • Report
  • 312 Pages
  • Global
From
Mammalian Polyclonal IgG Antibody Market by Animal Source, Application, Purification Method, End User, Formulation, Distribution Channel - Global Forecast to 2030 - Product Image

Mammalian Polyclonal IgG Antibody Market by Animal Source, Application, Purification Method, End User, Formulation, Distribution Channel - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Research Antibodies Market by Product Type, Source Type, Technology, Application, End User - Global Forecast to 2030 - Product Image

Research Antibodies Market by Product Type, Source Type, Technology, Application, End User - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Polyclonal Antibodies - Global Strategic Business Report - Product Image

Polyclonal Antibodies - Global Strategic Business Report

  • Report
  • 63 Pages
  • Global
From
Polyclonal Antibodies Market Report 2025 - Product Image

Polyclonal Antibodies Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Immunochemicals Market

The Immunochemicals market is a subset of the Immune Disorders Drugs market, which focuses on the development of treatments for diseases related to the immune system. Immunochemicals are a type of drug that modulate the immune system, either by stimulating or suppressing it. These drugs are used to treat a variety of conditions, including autoimmune diseases, allergies, and cancer. Immunochemicals can be administered orally, intravenously, or topically, depending on the condition being treated. Immunochemicals are often used in combination with other treatments, such as chemotherapy or radiation therapy, to maximize the effectiveness of the treatment. Additionally, immunochemicals can be used to reduce the side effects of other treatments, such as reducing inflammation or suppressing the immune system. Some companies in the Immunochemicals market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.